Summary of Study ST002661

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001020. The data can be accessed directly via it's Project DOI: 10.21228/M8V97D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002661
Study TitleMoTrPAC: Endurance exercise training study in young adult rats, Tissue:Heart - Targeted Acyl-CoA
Study SummaryThe goal of the endurance exercise training study in young adult rats (internal code: PASS1B-06) was to perform exercise training studies in adult (6 month) F344 rats, and from these rats collect as many tissues as feasible in order to provide high quality samples for detailed analysis by chemical analysis sites. Tissues were collected from 10-12 rats sedentary control rats concurrent with the collection of the 8-week training groups. The 8-week training group and controls were from the same cohort and same age at euthanasia (either 8). For the older age group, an additional set of controls (n=5-6) were collected with the 1-2 week training group. Rats were either sedentary or underwent an exercise training program. Rats were exercised on the rodent treadmill 5 days per week using a progressive training protocol designed to exercise the rats at approximately 70% of VO2max as outlined in the Table on the next page. Training was performed no earlier than 10:00 am and no later than 5:00 pm over 5 consecutive days per week. Training was initiated with the treadmill set at 70% of VO2 max (see tables) and 5 degrees grade for 20 minutes. The duration of exercise was increased by one minute each day until day 31 of training (start of week 7), when a duration of 50 min was reached. Speed and grade of each training session increased in larger increments due to treadmill parameters. The highest intensity and duration of training began on day 31. This intensity was maintained for the final 10 days of the protocol to ensure steady state had been achieved. If any rats were unable to perform at least 4 days of training per week they were removed from the study and euthanized. It is important to note that the starting treadmill speed varied depending on the sex and age of the rat. The initial and maximum speeds were based on VO2max measurements obtained during the pre-training testing of the compliant rats. Rats assigned to the control group followed a schedule similar to the training group. They were placed in one lane on the treadmill for 15 minutes/day, 5 days per week. The treadmill was set at 0 m/min at an incline that corresponded to the incline being used by the training group.
Institute
Duke University
DepartmentDuke Molecular Physiology Institute
LaboratoryMetabolomics Core Laboratory
Last NameNewgard
First NameChristopher
Address300 N Duke St, Durham, NC 27701
Emailchris.newgard@duke.edu
Phone(919) 668-6059
Submit Date2023-04-25
Raw Data AvailableYes
Raw Data File Type(s)TBD
Analysis Type DetailLC-MS
Release Date2023-10-06
Release Version1
Christopher Newgard Christopher Newgard
https://dx.doi.org/10.21228/M8V97D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001020
Project DOI:doi: 10.21228/M8V97D
Project Title:MoTrPAC
Project Summary:MoTrPAC is a national research consortium designed to discover and perform preliminary characterization of the range of molecular transducers (the "molecular map") that underlie the effects of physical activity in humans. The program's goal is to study the molecular changes that occur during and after exercise and ultimately to advance the understanding of how physical activity improves and preserves health. Preclinical and clinical studies will examine the systemic effects of endurance and resistance exercise across a range of ages and fitness levels by molecular probing of multiple tissues before and after acute and chronic exercise. This program is the largest targeted NIH investment of funds into the mechanisms of how physical activity improves health and prevents disease. The MoTrPAC program is supported by the NIH Common Fund and is managed by a trans-agency working group representing multiple NIH institutes and centers, led by the NIH Office of Strategic Coordination, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, and National Institute of Biomedical Imaging and Bioengineering. MoTrPAC Steering Committee: Wendy Kohrt, Chair, Russ Tracy, Co-Chair; NIH Program Manager, Concepcion Nierras. Euan Ashley and Matthew Wheeler are the PIs for the Motrpac Bioinformatics / Data Coordination Center.
Institute:MoTrPAC
Last Name:Ashley
First Name:Euan
Address:Falk Building CV267, 870 Quarry Road, Stanford, California 94305
Email:motrpac-data-deposition@lists.stanford.edu
Phone:(650) 725-1846

Subject:

Subject ID:SU002763
Subject Type:Mammal
Subject Species:Rattus norvegicus
Taxonomy ID:10116

Factors:

Subject type: Mammal; Subject species: Rattus norvegicus (Factor headings shown in green)

mb_sample_id local_sample_id Group Timepoint Sex
SA26416090266015810Control 8 weeks of training or control time Female
SA26416190248015810Control 8 weeks of training or control time Female
SA26416290245015810Control 8 weeks of training or control time Female
SA26416390252015810Control 8 weeks of training or control time Female
SA26416490265015810Control 8 weeks of training or control time Female
SA26416590237015810Control 8 weeks of training or control time Male
SA26416690232015810Control 8 weeks of training or control time Male
SA26416790217015810Control 8 weeks of training or control time Male
SA26416890239015810Control 8 weeks of training or control time Male
SA26416990229015810Control 8 weeks of training or control time Male
SA26417080022815818_3QC-ExternalStandard 0 hour -
SA26417180023825818_3QC-ExternalStandard 0 hour -
SA26417280023825818_2QC-ExternalStandard 0 hour -
SA26417380022815818_1QC-ExternalStandard 0 hour -
SA26417480022815818_2QC-ExternalStandard 0 hour -
SA26417580023825818_4QC-ExternalStandard 0 hour -
SA26417680022815818_4QC-ExternalStandard 0 hour -
SA26417780023825818_1QC-ExternalStandard 0 hour -
SA26417890567015810Training 1 week of training or control time Female
SA26417990560015810Training 1 week of training or control time Female
SA26418090571015810Training 1 week of training or control time Female
SA26418190564015810Training 1 week of training or control time Female
SA26418290559015810Training 1 week of training or control time Female
SA26418390426015810Training 1 week of training or control time Male
SA26418490423015810Training 1 week of training or control time Male
SA26418590421015810Training 1 week of training or control time Male
SA26418690430015810Training 1 week of training or control time Male
SA26418790422015810Training 1 week of training or control time Male
SA26418890581015810Training 2 weeks of training Female
SA26418990578015810Training 2 weeks of training Female
SA26419090587015810Training 2 weeks of training Female
SA26419190576015810Training 2 weeks of training Female
SA26419290585015810Training 2 weeks of training Female
SA26419390444015810Training 2 weeks of training Male
SA26419490439015810Training 2 weeks of training Male
SA26419590450015810Training 2 weeks of training Male
SA26419690441015810Training 2 weeks of training Male
SA26419790449015810Training 2 weeks of training Male
SA26419890416015810Training 4 weeks of training Female
SA26419990412015810Training 4 weeks of training Female
SA26420090420015810Training 4 weeks of training Female
SA26420190410015810Training 4 weeks of training Female
SA26420290406015810Training 4 weeks of training Female
SA26420390289015810Training 4 weeks of training Male
SA26420490281015810Training 4 weeks of training Male
SA26420590283015810Training 4 weeks of training Male
SA26420690280015810Training 4 weeks of training Male
SA26420790292015810Training 4 weeks of training Male
SA26420890254015810Training 8 weeks of training or control time Female
SA26420990267015810Training 8 weeks of training or control time Female
SA26421090258015810Training 8 weeks of training or control time Female
SA26421190259015810Training 8 weeks of training or control time Female
SA26421290251015810Training 8 weeks of training or control time Female
SA26421390225015810Training 8 weeks of training or control time Male
SA26421490222015810Training 8 weeks of training or control time Male
SA26421590223015810Training 8 weeks of training or control time Male
SA26421690227015810Training 8 weeks of training or control time Male
SA26421790218015810Training 8 weeks of training or control time Male
Showing results 1 to 58 of 58

Collection:

Collection ID:CO002756
Collection Summary:-
Sample Type:Heart

Treatment:

Treatment ID:TR002772
Treatment Summary:-

Sample Preparation:

Sampleprep ID:SP002769
Sampleprep Summary:500 ul of tissue homogenate preprared at 50 mg/ml in 50% acetonitrile/0.3% formic acid are spiked with C17 Acyl CoA. The acyl CoAs are purified by solid phase extraction using 2-(2-pyridyl) ethyl functionalized Silica gel (Sigma-Aldrich 54127-U).
Sampleprep Protocol Filename:pass1b_experimental_design_metabolomics.pdf

Combined analysis:

Analysis ID AN004333
Analysis type MS
Chromatography type Flow induction analysis
Chromatography system Waters Acquity UPLC
Column No column
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Waters Xevo TQ-S
Ion Mode POSITIVE
Units pmol/mg of tissue

Chromatography:

Chromatography ID:CH003239
Chromatography Summary:80% methanol/20% water containing 30 mM ammonium hydroxide is used as the mobile phase, the flow is 0.030 ml/min.
Methods Filename:pass1b_acoa_methods.pdf
Instrument Name:Waters Acquity UPLC
Column Name:No column
Chromatography Type:Flow induction analysis

MS:

MS ID:MS004080
Analysis ID:AN004333
Instrument Name:Waters Xevo TQ-S
Instrument Type:Triple quadrupole
MS Type:ESI
MS Comments:Ion ratios of endogenous acyl CoAs to the C-17 CoA internal standard are computed from centroided spectra using a software package NeoLynx (Waters, Milford, MA). The ratios are converted to concentrations using calibrators prepared by spiking tissue homogenates with authentic CoAs (Sigma, St. Louis , MO) having saturated acyl chain lengths C0- C18. Corrections for the heavy isotope effects, mainly 13C, to the adjacent m+2 spectral peaks in a particular chain length cluster are made empirically by referring to the observed spectra for the analytical standards. The values are expressed in pmol/mg. Spectra are acquired in the multichannel acquisition mode monitoring the neutral loss of 507 amu (phosphoadenosine diphosphate) and scanning from m/z 750 to1060.
Ion Mode:POSITIVE
  logo